Pfizer partners with South Africa to produce pneumococcal vaccine

CAPE TOWN, Nov 3 (Reuters) - Global pharmaceutical company, Pfizer, has partnered with South Africa's Biovac Institute to produce a potentially life-saving pneumonia vaccine for infants, a cabinet minister said on Tuesday.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.